Janus Henderson Investors US’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
$3.36M Sell
543,962
-27,241
-5% -$168K ﹤0.01% 855
2016
Q4
$3.23M Buy
571,203
+1,619
+0.3% +$9.15K ﹤0.01% 908
2016
Q3
$8.42M Buy
569,584
+2,977
+0.5% +$44K 0.01% 729
2016
Q2
$5.09M Sell
566,607
-34,700
-6% -$312K ﹤0.01% 779
2016
Q1
$5.56M Buy
601,307
+48,929
+9% +$453K ﹤0.01% 760
2015
Q4
$6.97M Buy
552,378
+49,396
+10% +$623K 0.01% 770
2015
Q3
$6.55M Buy
502,982
+128,202
+34% +$1.67M 0.01% 790
2015
Q2
$8.18M Buy
+374,780
New +$8.18M 0.01% 731